These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 30753560)

  • 1. The Influence of Preoperative Medications on Postoperative Complications in Patients After Intestinal Surgery for Crohn's Disease.
    Yu CS; Jung SW; Lee JL; Lim SB; Park IJ; Yoon YS; Kim CW; Yang SK; Ye BD; Park SH; Han M; Kim JC
    Inflamm Bowel Dis; 2019 Aug; 25(9):1559-1568. PubMed ID: 30753560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease.
    Safroneeva E; Vavricka SR; Fournier N; Pittet V; Peyrin-Biroulet L; Straumann A; Rogler G; Schoepfer AM;
    Aliment Pharmacol Ther; 2015 Oct; 42(8):977-89. PubMed ID: 26271358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients.
    Syed A; Cross RK; Flasar MH
    Am J Gastroenterol; 2013 Apr; 108(4):583-93. PubMed ID: 23481144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Anti-TNF Therapy is Associated with a Shorter Length of Resected Bowel in Patients Undergoing Ileocolic Resection for Crohn's Disease.
    Huang Y; Yao D; Guo F; Zhou Z; Li Y
    J Invest Surg; 2022 Jun; 35(6):1357-1365. PubMed ID: 34983280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study.
    Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
    Aliment Pharmacol Ther; 2013 Jan; 37(2):214-24. PubMed ID: 23190161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohn's disease.
    Kanazawa A; Yamana T; Okamoto K; Sahara R
    Dis Colon Rectum; 2012 Sep; 55(9):957-62. PubMed ID: 22874602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.
    Fumery M; Seksik P; Auzolle C; Munoz-Bongrand N; Gornet JM; Boschetti G; Cotte E; Buisson A; Dubois A; Pariente B; Zerbib P; Chafai N; Stefanescu C; Panis Y; Marteau P; Pautrat K; Sabbagh C; Filippi J; Chevrier M; Houze P; Jouven X; Treton X; Allez M;
    Am J Gastroenterol; 2017 Feb; 112(2):337-345. PubMed ID: 27958285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of perioperative immunosuppressive medication on early outcome in Crohn's disease patients.
    Indar AA; Young-Fadok TM; Heppell J; Efron JE
    World J Surg; 2009 May; 33(5):1049-52. PubMed ID: 19277774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Necrosis Factor Alpha Inhibitors Did Not Influence Postoperative Morbidity After Elective Surgical Resections in Crohn's Disease.
    Kotze PG; Saab MP; Saab B; da Silva Kotze LM; Olandoski M; Pinheiro LV; Martinez CA; Ayrizono ML; Magro DO; Coy CS
    Dig Dis Sci; 2017 Feb; 62(2):456-464. PubMed ID: 27933472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all.
    Melmed GY; Spiegel BM; Bressler B; Cheifetz AS; Devlin SM; Harrell LE; Irving PM; Jones J; Kaplan GG; Kozuch PL; Velayos FS; Baidoo L; Sparrow MP; Siegel CA
    Clin Gastroenterol Hepatol; 2010 Aug; 8(8):655-9. PubMed ID: 20451665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor necrosis factor and postoperative complications in Crohn's disease: systematic review and meta-analysis.
    Kopylov U; Ben-Horin S; Zmora O; Eliakim R; Katz LH
    Inflamm Bowel Dis; 2012 Dec; 18(12):2404-13. PubMed ID: 22467533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn's disease?
    White EC; Melmed GY; Vasiliauskas E; Dubinsky M; Ippoliti A; McGovern D; Targan S; Fleshner P
    Dis Colon Rectum; 2012 May; 55(5):563-8. PubMed ID: 22513435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy.
    Myrelid P; Marti-Gallostra M; Ashraf S; Sunde ML; Tholin M; Oresland T; Lovegrove RE; Tøttrup A; Kjaer DW; George BD
    Br J Surg; 2014 Apr; 101(5):539-45. PubMed ID: 24615529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-TNF Therapy Is Associated With an Increased Risk of Postoperative Morbidity After Surgery for Ileocolonic Crohn Disease: Results of a Prospective Nationwide Cohort.
    Brouquet A; Maggiori L; Zerbib P; Lefevre JH; Denost Q; Germain A; Cotte E; Beyer-Berjot L; Munoz-Bongrand N; Desfourneaux V; Rahili A; Duffas JP; Pautrat K; Denet C; Bridoux V; Meurette G; Faucheron JL; Loriau J; Guillon F; Vicaut E; Benoist S; Panis Y;
    Ann Surg; 2018 Feb; 267(2):221-228. PubMed ID: 29300710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative Morbidity Risks Following Ileocolic Resection for Crohn's Disease Treated With Anti-TNF Alpha Therapy: A Retrospective Study of 360 Patients.
    Jouvin I; Lefevre JH; Creavin B; Pitel S; Chafai N; Tiret E; Beaugerie L; Parc Y;
    Inflamm Bowel Dis; 2018 Jan; 24(2):422-432. PubMed ID: 29361093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-TNF and Postoperative Complications in Abdominal Crohn's Disease Surgery.
    Yamamoto T; Teixeira FV; Saad-Hossne R; Kotze PG; Danese S
    Curr Drug Targets; 2019; 20(13):1339-1348. PubMed ID: 30947671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of immunomodulators and biologics on indication for surgical bowel resection in children with Crohn's disease.
    Zimmerman LA; Shamberger RC; Valim C; Bousvaros A
    Inflamm Bowel Dis; 2014 Jun; 20(6):1015-20. PubMed ID: 24788215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease.
    Nasir BS; Dozois EJ; Cima RR; Pemberton JH; Wolff BG; Sandborn WJ; Loftus EV; Larson DW
    J Gastrointest Surg; 2010 Dec; 14(12):1859-65; discussion 1865-6. PubMed ID: 20872084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of immune therapy on surgical site infection following Crohn's Disease resection.
    Serradori T; Germain A; Scherrer ML; Ayav C; Perez M; Romain B; Palot JP; Rohr S; Peyrin-Biroulet L; Bresler L
    Br J Surg; 2013 Jul; 100(8):1089-93. PubMed ID: 23649458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoalbuminaemia, Not Biologic Exposure, Is Associated with Postoperative Complications in Crohn's Disease Patients Undergoing Ileocolic Resection.
    Shah RS; Bachour S; Jia X; Holubar SD; Hull TL; Achkar JP; Philpott J; Qazi T; Rieder F; Cohen BL; Regueiro MD; Lightner AL; Click BH
    J Crohns Colitis; 2021 Jul; 15(7):1142-1151. PubMed ID: 33388775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.